title: Induction of parturition with aglepristone in various sized bitches of different breeds.
abstract: The objective of this study was to confirm in various breeds of dogs the efficacy and safety of a parturition induction treatment described to be successful in Beagle dogs. Parturition was induced in seven various sized pregnant bitches of different breeds, with 15 mg aglepristone per kg at day 59-61 post-estimated ovulation day, followed 24 h later by 0.15 IU oxytocin per kg subcutaneous injections every 2 h. Two bitches were small-sized bitches (<10 kg), three bitches were large-sized bitches (30-40 kg) and two bitches were giant bitches (>40 kg). The results were compared to a control group (n = 6), in which bitches underwent a natural delivery in the same environmental conditions as the induced group. In the induced group, parturition was successfully induced in 7/7 bitches. The first pup in a litter was born on average 25.9 +/- 3.29 h after aglepristone administration (21-30 h). Two of seven bitches from the small-sized group delivered some of their pups before the first administration of oxytocin. The mean duration of parturition was 9.6 +/- 5.4 h vs 8.0 +/- 4.8 h in the control group. The mean interval between two successive pups being delivered was 115.6 +/- 82.8 min (34-265) vs 68.8 +/- 24.5 min in the control group (p < 0.03). The mean weight at parturition did not differ significantly between the two groups. One litter of four Yorkshire Terrier pups in the induced group were premature at the time of birth and died between 19 and 29 h post-delivery. This study, although on a very limited number of dogs, confirms the efficacy of the aglepristone/oxytocin protocol to induce parturition in dogs.
authors.affiliation: Reproduction Animale, Ecole Nationale Vétérinaire, Maisons-Alfort, France. afontbonne@vet-alfort.fr
authors.forename: A
authors.initials: A
authors.lastname: Fontbonne
authors.forename: E
authors.initials: E
authors.lastname: Fontaine
authors.forename: X
authors.initials: X
authors.lastname: Lévy
authors.forename: R
authors.initials: R
authors.lastname: Bachellerie
authors.forename: F
authors.initials: F
authors.lastname: Bernex
authors.forename: S
authors.initials: S
authors.lastname: Atam-Kassigadou
authors.forename: M
authors.initials: M
authors.lastname: Guffroy
authors.forename: E
authors.initials: E
authors.lastname: Leblond
authors.forename: E
authors.initials: E
authors.lastname: Briant
mesh_terms: D000818:Animals; D049628:Body Size; D004285:Dogs / Q000033:anatomy & histology / Q000235:genetics; D004963:Estrenes / Q000494:pharmacology*; D005260:Female; D007751:Labor, Induced / Q000662:veterinary*; D010120:Oxytocics / Q000494:pharmacology*; D011247:Pregnancy
chemical_list: D004963:Estrenes; D010120:Oxytocics; C419063:aglepristone